vs

Side-by-side financial comparison of Broadridge Financial Solutions (BR) and Quest Diagnostics (DGX). Click either name above to swap in a different company.

Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $1.7B, roughly 1.7× Broadridge Financial Solutions). Broadridge Financial Solutions runs the higher net margin — 16.6% vs 9.7%, a 6.9% gap on every dollar of revenue. On growth, Quest Diagnostics posted the faster year-over-year revenue change (9.2% vs -5.4%). Over the past eight quarters, Broadridge Financial Solutions's revenue compounded faster (10.4% CAGR vs 9.9%).

Broadridge Financial Solutions, Inc. is a public corporate services and financial technology company. Headquartered in Lake Success, New York, the company was founded in 2007 as a spin-off from Automatic Data Processing. Broadridge supplies companies in the financial industry with financial documents such as proxy statements and annual reports, as well as shareholder communications solutions such as virtual annual meetings.

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

BR vs DGX — Head-to-Head

Bigger by revenue
DGX
DGX
1.7× larger
DGX
$2.9B
$1.7B
BR
Growing faster (revenue YoY)
DGX
DGX
+14.6% gap
DGX
9.2%
-5.4%
BR
Higher net margin
BR
BR
6.9% more per $
BR
16.6%
9.7%
DGX
Faster 2-yr revenue CAGR
BR
BR
Annualised
BR
10.4%
9.9%
DGX

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
BR
BR
DGX
DGX
Revenue
$1.7B
$2.9B
Net Profit
$284.6M
$281.0M
Gross Margin
27.6%
Operating Margin
12.0%
15.4%
Net Margin
16.6%
9.7%
Revenue YoY
-5.4%
9.2%
Net Profit YoY
17.1%
12.0%
EPS (diluted)
$2.42
$2.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BR
BR
DGX
DGX
Q1 26
$2.9B
Q4 25
$1.7B
$2.8B
Q3 25
$2.8B
Q2 25
$2.1B
$2.8B
Q1 25
$1.8B
$2.7B
Q4 24
$1.6B
$2.6B
Q3 24
$1.4B
$2.5B
Q2 24
$1.9B
$2.4B
Net Profit
BR
BR
DGX
DGX
Q1 26
$281.0M
Q4 25
$284.6M
$245.0M
Q3 25
$245.0M
Q2 25
$374.2M
$282.0M
Q1 25
$243.1M
$220.0M
Q4 24
$142.4M
$222.0M
Q3 24
$79.8M
$226.0M
Q2 24
$323.2M
$229.0M
Gross Margin
BR
BR
DGX
DGX
Q1 26
Q4 25
27.6%
32.4%
Q3 25
33.7%
Q2 25
37.3%
34.2%
Q1 25
31.8%
32.5%
Q4 24
27.9%
32.7%
Q3 24
24.5%
32.6%
Q2 24
35.5%
33.5%
Operating Margin
BR
BR
DGX
DGX
Q1 26
15.4%
Q4 25
12.0%
13.8%
Q3 25
13.7%
Q2 25
24.1%
15.9%
Q1 25
19.0%
13.0%
Q4 24
13.3%
13.8%
Q3 24
9.4%
13.3%
Q2 24
22.7%
14.8%
Net Margin
BR
BR
DGX
DGX
Q1 26
9.7%
Q4 25
16.6%
8.7%
Q3 25
8.7%
Q2 25
18.1%
10.2%
Q1 25
13.4%
8.3%
Q4 24
9.0%
8.5%
Q3 24
5.6%
9.1%
Q2 24
16.6%
9.6%
EPS (diluted)
BR
BR
DGX
DGX
Q1 26
$2.24
Q4 25
$2.42
$2.18
Q3 25
$2.16
Q2 25
$3.17
$2.47
Q1 25
$2.05
$1.94
Q4 24
$1.20
$1.95
Q3 24
$0.68
$1.99
Q2 24
$2.72
$2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BR
BR
DGX
DGX
Cash + ST InvestmentsLiquidity on hand
$371.5M
$393.0M
Total DebtLower is stronger
$3.2B
$5.7B
Stockholders' EquityBook value
$2.9B
$7.7B
Total Assets
$8.6B
$16.7B
Debt / EquityLower = less leverage
1.10×
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BR
BR
DGX
DGX
Q1 26
$393.0M
Q4 25
$371.5M
$420.0M
Q3 25
$432.0M
Q2 25
$562.2M
$319.0M
Q1 25
$317.9M
$188.0M
Q4 24
$290.6M
$549.0M
Q3 24
$293.5M
$764.0M
Q2 24
$305.2M
$271.0M
Total Debt
BR
BR
DGX
DGX
Q1 26
$5.7B
Q4 25
$3.2B
$5.2B
Q3 25
$5.2B
Q2 25
$3.3B
$5.2B
Q1 25
$3.4B
$5.9B
Q4 24
$3.7B
$5.6B
Q3 24
$3.6B
$5.6B
Q2 24
$3.4B
$3.8B
Stockholders' Equity
BR
BR
DGX
DGX
Q1 26
$7.7B
Q4 25
$2.9B
$7.2B
Q3 25
$7.3B
Q2 25
$2.7B
$7.2B
Q1 25
$2.4B
$6.9B
Q4 24
$2.2B
$6.8B
Q3 24
$2.2B
$6.8B
Q2 24
$2.2B
$6.6B
Total Assets
BR
BR
DGX
DGX
Q1 26
$16.7B
Q4 25
$8.6B
$16.2B
Q3 25
$16.2B
Q2 25
$8.5B
$16.0B
Q1 25
$8.3B
$15.8B
Q4 24
$8.2B
$16.2B
Q3 24
$8.0B
$16.1B
Q2 24
$8.2B
$13.9B
Debt / Equity
BR
BR
DGX
DGX
Q1 26
0.74×
Q4 25
1.10×
0.72×
Q3 25
0.71×
Q2 25
1.22×
0.72×
Q1 25
1.44×
0.85×
Q4 24
1.64×
0.83×
Q3 24
1.63×
0.83×
Q2 24
1.55×
0.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BR
BR
DGX
DGX
Operating Cash FlowLast quarter
$278.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BR
BR
DGX
DGX
Q1 26
$278.0M
Q4 25
$465.0M
Q3 25
$563.0M
Q2 25
$699.7M
$544.0M
Q1 25
$360.4M
$314.0M
Q4 24
$236.7M
$464.0M
Q3 24
$-125.5M
$356.0M
Q2 24
$721.0M
$360.0M
Free Cash Flow
BR
BR
DGX
DGX
Q1 26
Q4 25
$307.0M
Q3 25
$419.0M
Q2 25
$684.1M
$436.0M
Q1 25
$348.9M
$197.0M
Q4 24
$227.9M
$341.0M
Q3 24
$-133.4M
$250.0M
Q2 24
$703.2M
$268.0M
FCF Margin
BR
BR
DGX
DGX
Q1 26
Q4 25
10.9%
Q3 25
14.9%
Q2 25
33.1%
15.8%
Q1 25
19.3%
7.4%
Q4 24
14.3%
13.0%
Q3 24
-9.4%
10.0%
Q2 24
36.2%
11.2%
Capex Intensity
BR
BR
DGX
DGX
Q1 26
3.9%
Q4 25
5.6%
Q3 25
5.1%
Q2 25
0.8%
3.9%
Q1 25
0.6%
4.4%
Q4 24
0.6%
4.7%
Q3 24
0.6%
4.3%
Q2 24
0.9%
3.8%
Cash Conversion
BR
BR
DGX
DGX
Q1 26
0.99×
Q4 25
1.90×
Q3 25
2.30×
Q2 25
1.87×
1.93×
Q1 25
1.48×
1.43×
Q4 24
1.66×
2.09×
Q3 24
-1.57×
1.58×
Q2 24
2.23×
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BR
BR

Recurring Fee Revenue Investor Communication Solutions$589.5M34%
Recurring Fee Revenue Capital Markets$300.9M18%
Recurring Fee Revenue Regulatory$248.7M15%
Recurring Fee Revenue Customer Communications$189.2M11%
Recurring Fee Revenue Wealth And Investment Management$179.7M10%
Recurring Fee Revenue Data Driven Fund Solutions$112.7M7%
Event Driven Revenue Mutual Funds$51.4M3%
Event Driven Revenue Equity And Other$39.2M2%
Global Technology And Operations$7.5M0%

DGX
DGX

Segment breakdown not available.

Related Comparisons